Boston Scientific (BSX) Other Non Operating Income (2009 - 2026)

Boston Scientific (BSX) has 18 years of Other Non Operating Income data on file, last reported at $61.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non Operating Income rose 152.59% year-over-year to $61.0 million; the trailing twelve-month figure through Mar 2026 stood at $126.0 million (up 159.72% YoY), and the FY2025 full-year result was -$228.0 million, down 1325.0% from the prior year.
• Other Non Operating Income climbed to $61.0 million in Q1 2026, from -$125.0 million in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $213.0 million in Q2 2025 to a low of -$412.0 million in Q4 2022.
• A 5-year average of -$40.3 million and a median of -$18.0 million in 2023 frame the typical range for Other Non Operating Income.
• Peak annual rise in Other Non Operating Income reached 313.0% in 2025, while the deepest fall reached 5900.0% in 2025.
• Tracing BSX's Other Non Operating Income over 5 years: stood at -$412.0 million in 2022, then surged by 96.36% to -$15.0 million in 2023, then jumped by 40.0% to -$9.0 million in 2024, then plunged by 1288.89% to -$125.0 million in 2025, then jumped by 148.8% to $61.0 million in 2026.
• Business Quant data shows BSX's Other Non Operating Income at $61.0 million in Q1 2026, -$125.0 million in Q4 2025, and -$23.0 million in Q3 2025.